Nav: Home

Popular Hepatitis News and Current Events

Popular Hepatitis News and Current Events, Hepatitis News Articles.
Sort By: Most Relevant | Most Recent
Page 1 of 25 | 1000 Results
Morris Animal Foundation study identifies new virus in cat
Morris Animal Foundation-funded researchers from the University of Sydney have found a previously undiscovered hepadnavirus in an immunocompromised cat, and subsequently in banked samples. (2018-05-17)
Icelandic program seeks to eliminate HCV
A new Journal of Internal Medicine study describes an innovative program to eliminate hepatitis C virus (HCV) as a public health threat in Iceland. (2018-03-07)
Hepatitis C virus screening rates remain low among baby boomers
Despite the steady increase of liver cancer incidence in the United States in recent decades, data from 2015 indicates that less than 13 percent of individuals born between 1945 and 1965 are estimated to have undergone screening for hepatitis C virus (HCV). (2018-03-27)
How to select anti-hepatitis B virus agents for drug-resistance patients?
Chronic hepatitis B virus (HBV) infection remains a global public health problem. (2008-09-24)
Vitamin D deficiency common in patients with IBD, chronic liver disease
The 73rd Annual Scientific Meeting of the American College of Gastroenterology in Orlando found patients with inflammatory bowel disease or chronic liver disease were at increased risk of developing Vitamin D deficiencies. (2008-10-06)
Nano vaccine for hepatitis B shows promise for third world
A new needle-less vaccine is highly effective and can be stored without refrigeration, University of Michigan studies in animals show. (2008-08-12)
Screening for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis achieving sustained virological response is likely to be cost effective
A Canadian study suggests that biannual or annual ultrasound screening for HCC is likely to be cost effective after a sustained virological response in those with hepatitis C-related cirrhosis, but not in those with advanced fibrosis without cirrhosis. (2018-04-12)
Hepatitis C: A novel point-of-care assay
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus is the diagnosis of chronic cases that are generally asymptomatic. (2018-04-10)
The risk factors of idiopathic pulmonary fibrosis in HCV patients
A group from Toranomon Hospital of Japan investigated the cumulative development incidence and predictive factors for idiopathic pulmonary fibrosis in HCV positive patients. (2008-10-23)
Hepatitis C virus elimination programmes report encouraging results: Is elimination within reach?
ILC 2018: National programmes in Georgia and Iceland report high levels of engagement, treatment initiation, and cure, suggesting HCV elimination targets are achievable. (2018-04-13)
Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
New research published in the Journal of the American College of Surgeons shows long-term survival and liver rejection rates are equivalent for African-American liver transplant patients as compared with patients of other races. (2008-05-19)
HEPAHEALTH Project Report -- risk factors and the burden of liver disease in Europe and selected Central Asian countries
The HEPAHEALTH Project Report, which was presented today in a press conference at The International Liver Congress trade; 2018 in Paris, France, is the second overview commissioned by EASL on the burden of liver disease in Europe. (2018-04-12)
Linkage to care specialist facilitates access to hepatitis C treatment for people who inject drugs
A longitudinal study involving more than 1,000 individuals reports promising role for linkage to care specialists in expanding access to hepatitis C treatment for people who inject drugs. (2018-04-12)
HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs
HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs. (2018-04-13)
Sustained virological response to oral hepatitis C virus treatment associated with reduced mortality in an Italian cohort
A large-scale, real-world data on the course of liver disease after clearance of HCV with direct-acting antiviral agents show reduced risk of death at all stages of disease. (2018-04-13)
'Exciting' discovery on path to develop new type of vaccine to treat global viruses
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world. (2017-09-15)
Discovery of new Hepatitis C virus mechanism
Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus with the potential of improving pathological liver conditions. (2016-07-27)
A new protocol for Hepatitis A vaccination to prevent a vaccine-resistant virus
Researchers of the University of Barcelona (UB) have analysed, with massive sequencing techniques for the first time, the evolution of the Hepatitis A virus with samples from patients. (2019-02-08)
New MRI tech could help doctors detect heart disease with better accuracy
Doctors might be able to better detect any disease or disorder that involves inflammation thanks to a new MRI imaging technology co-developed by faculty at Binghamton University, State University of New York. (2017-12-13)
Hepatitis C virus may need enzyme's help to cause liver disease
A key enzyme may explain how hepatitis C infection leads to serious liver diseases, reports the University of Pittsburgh Graduate School of Public Health. (2008-07-09)
Hepatitis therapy: Kupffer cells adjust the balance between pathogen control and hepatocyte regenera
Scientists from TWINCORE have now published new insights on the processes involved in liver inflammation in the Journal of Hepatology: Type I interferons, on the one hand, limit viral replication and thereby help the immune cells to control the viral pathogen. (2018-01-17)
New affordable hepatitis C combination treatment shows 97 percent cure rate
The sofosbuvir/ravidasvir combination treatment for hepatitis C has been shown to be safe and effective, with extremely high cure rates, according to interim results from the Phase II/III STORM-C-1 trial presented by DNDi at the International Liver Conference in Paris. (2018-04-12)
Insurance denials for new hepatitis C drugs remain high nationwide, study suggests
Highly effective drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the US in 2014. (2018-06-07)
Counterattack of the hepatitis B virus
The hepatitis B virus (HBV) infects liver cells. Drugs are available to treat HBV, but they rarely cure the infection, and so the virus typically returns after the treatment ends. (2016-03-16)
Who found some new mechanisms of HBV virulence?
Despite the existence of safe and efficient vaccines, hepatitis B virus is one of the most deadly viruses in the world, killing about 1.2 million people every year. (2008-02-22)
Study finds racial differences in cure rates for Hepatitis C
In a large ethnically diverse group of patients seen at a community-based Veterans Affairs practice, cure rates for chronic hepatitis C were lower for African American individuals relative to White individuals, even when patients were receiving optimal therapies. (2018-02-22)
New test allows for one-step diagnosis of HCV infection
The current standard in diagnosing Hepatitis C virus (HCV) infection requires two sequential steps that make it suboptimal, costly, inconvenient, time consuming, and globally not widely available or affordable. (2016-06-07)
Organ-on-chip technology enters next stage as experts test hepatitis B virus
Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs. (2018-02-14)
Could the biological clock be a key ally in the fight against inflammatory disease?
What if the symptoms and seriousness of certain inflammatory diseases were linked to time of day? (2018-01-26)
How viruses disarm the immune system
How do viruses that cause chronic infections, such as HIV or hepatitis c virus, manage to outsmart their hosts' immune systems? (2018-02-05)
The positive and negative role of LRH-1 during inflammation
The research group around Professor Thomas Brunner at the University of Konstanz discovers the role that the LRH-1 protein plays in the immune system -- inhibiting this protein could help treat inflammatory diseases. (2019-07-25)
Global burden of disease study focuses on liver cancer
A new article published by JAMA Oncology reports the results of the Global Burden of Disease 2015 study on primary liver cancer incidence, death and years of healthy life lost in 195 countries or territories from 1990 to 2015. (2017-10-05)
Punjab, India: Mass treatment of a population with chronic hepatitis C infection produces high rates of cure
A program of decentralized public healthcare achieves high rates of cure regardless of genotype or the presence of cirrhosis: the Punjab Model. (2018-04-12)
First real-world studies report glecaprevir/pibrentasvir to be effective and well tolerated in chronic HCV infection
Studies conducted in Italy and Germany confirm the effectiveness and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection, with viral suppression rates similar to those observed in clinical trials. (2018-04-12)
Cancer stem cells, allies of the tumor and enemies of the patient
Research results point to a therapeutic value for the protein (Ahr) because controlling it might repress the pluripotency of the cancer stem cell and reduce the malignity of the tumour. (2018-03-05)
'Increased risk' donor organs a tough sell to transplant patients
The opioid epidemic has created a tragic surge in donor organs. (2017-10-05)
Opioid abuse leads to heroin use and a hepatitis C epidemic, USC researcher says
Heroin is worse than other drugs because people inject it much sooner, potentially resulting in increased risk of injection-related epidemics such as hepatitis C and HIV, a Keck School of Medicine of USC study shows. (2018-02-22)
Hepatitis C increasing among pregnant women
Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia. (2017-05-11)
Hepatitis C tied to increased risk of Parkinson's
The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the Dec. (2015-12-23)
Cellular mechanism for severe viral hepatitis identified
KAIST medical scientists identified a cellular mechanism causing inflammatory changes in regulatory T cells that can lead to severe viral hepatitis. (2018-01-18)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...